9-(2-Phosphonylmethoxyethyl) adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system

Nicoletta Villani; R Caliò; E Balestra; Jan Balzarini; De Clercq Erik; Emanuele Fabrizi; Carlo Federico Perno; V. Del Gobbo

doi:10.1016/0166-3542(94)90098-1

Back

9-(2-Phosphonylmethoxyethyl) adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system

Article 1994 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1992

Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine.

Lieve Naesens, Jan Balzarini, De Clercq Erik

Article1991

Transplacental Antiretroviral Therapy with 9-(2-Phosphonylmethoxyethyl)adenine Is Embryotoxic in Transgenic Mice

John S. Lee, Steve Mullaney, Rod T. Bronson, Arlene H. Sharpe, Rudolf Jaenisch, Jan Balzarini, De Clercq Erik, Ruth M. Ruprecht

Article2001

Carrier-Mediated Delivery Improves the Efficacy of 9-(2-Phosphonylmethoxyethyl)Adenine against Hepatitis B Virus

Martin K. Bijsterbosch, Chunxiao Ying, Remco L.A. de Vrueh, De Clercq Erik, Erik A.L. Biessen, Johan Neyts, Theo J.C. van Berkel

Article1998

Efficacy of the Acyclic Nucleoside Phosphonates(S)-9-(3-Fluoro-2-Phosphonylmethoxypropyl)Adenine (FPMPA) and 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) Against Feline Immunodeficiency Virus

Katrin Hartmann, M Kuffer, Jan Balzarini, Lieve Naesens, Michel Goldberg, Volker Erfle, Frank-Detlef Goebel, De Clercq Erik, Jindřich Jindřich, Antonı́n Holý, Norbert Bischofberger, W Kraft

Article1994

Therapeutic potential of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) as an antiviral drug

Lieve Naesens, Jan Balzarini, De Clercq Erik